Hudhaifah Shaker1, Zeinab Mahate1, Grit Dabritz1, Mohammed S Absar2. 1. Department of Breast Surgery, Pennine Acute Hospitals NHS Trust, Manchester, U.K. 2. Department of Breast Surgery, Pennine Acute Hospitals NHS Trust, Manchester, U.K. Mohammed.Absar@pat.nhs.uk.
Abstract
BACKGROUND/AIM: Symptomatic cancers display a different biological behaviour from screen-detected cancers, which may impact the management of axillary metastases. We aimed to determine the role of unselected axillary nodal clearance (ANC) in symptomatic patients with positive sentinel node biopsies (SNBs). PATIENTS AND METHODS: A case-note review was performed on 95 symptomatic breast cancer patients who underwent ANC following positive SNB. RESULTS: Thirty-eight (40%) patients were treated with a mastectomy and 57 (60%) with breast-conserving surgery. At ANC, 25 patients (26.3%) showed evidence of further lymph node metastases, with 15 (60%) having two or fewer macrometastases. The presence of more than 2 SNB macrometastases was associated with further ANC metastases (p<0.001). The presence of further metastases at ANC was not associated with either reduced overall survival or disease-free survival. CONCLUSION: A number of symptomatic breast cancer patients with positive SNBs may be overtreated. Ongoing trials examining the management of low volume SNB macrometastases need to consider the symptomatic subgroup in their conclusions. Copyright
BACKGROUND/AIM: Symptomatic cancers display a different biological behaviour from screen-detected cancers, which may impact the management of axillary metastases. We aimed to determine the role of unselected axillary nodal clearance (ANC) in symptomatic patients with positive sentinel node biopsies (SNBs). PATIENTS AND METHODS: A case-note review was performed on 95 symptomatic breast cancerpatients who underwent ANC following positive SNB. RESULTS: Thirty-eight (40%) patients were treated with a mastectomy and 57 (60%) with breast-conserving surgery. At ANC, 25 patients (26.3%) showed evidence of further lymph node metastases, with 15 (60%) having two or fewer macrometastases. The presence of more than 2 SNB macrometastases was associated with further ANC metastases (p<0.001). The presence of further metastases at ANC was not associated with either reduced overall survival or disease-free survival. CONCLUSION: A number of symptomatic breast cancerpatients with positive SNBs may be overtreated. Ongoing trials examining the management of low volume SNB macrometastases need to consider the symptomatic subgroup in their conclusions. Copyright
Authors: Á Sávolt; G Péley; C Polgár; N Udvarhelyi; G Rubovszky; E Kovács; B Győrffy; M Kásler; Z Mátrai Journal: Eur J Surg Oncol Date: 2017-01-16 Impact factor: 4.424
Authors: Monica Morrow; Kimberly J Van Zee; Sujata Patil; Oriana Petruolo; Anita Mamtani; Andrea V Barrio; Deborah Capko; Mahmoud El-Tamer; Mary L Gemignani; Alexandra S Heerdt; Laurie Kirstein; Melissa Pilewskie; George Plitas; Virgilio S Sacchini; Lisa M Sclafani; Alice Ho; Hiram S Cody Journal: Ann Surg Date: 2017-09 Impact factor: 12.969
Authors: Umberto Veronesi; Giovanni Paganelli; Giuseppe Viale; Alberto Luini; Stefano Zurrida; Viviana Galimberti; Mattia Intra; Paolo Veronesi; Chris Robertson; Patrick Maisonneuve; Giuseppe Renne; Concetta De Cicco; Francesca De Lucia; Roberto Gennari Journal: N Engl J Med Date: 2003-08-07 Impact factor: 91.245
Authors: P C Allgood; S W Duffy; O Kearins; E O'Sullivan; N Tappenden; M G Wallis; G Lawrence Journal: Br J Cancer Date: 2011-05-03 Impact factor: 7.640